Litigation Details for Amgen Inc. v. Hospira, Inc. (D. Del. 2020)
✉ Email this page to a colleague
Amgen Inc. v. Hospira, Inc. (D. Del. 2020)
Docket | ⤷ Sign Up | Date Filed | 2020-02-11 |
Court | District Court, D. Delaware | Date Terminated | 2022-03-21 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,228,398; 8,105,626; 8,173,158; 8,461,187 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Amgen Inc. v. Hospira, Inc.
Details for Amgen Inc. v. Hospira, Inc. (D. Del. 2020)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2021-09-10 | 94 | Redacted Document | incorporation by reference of two separate patents, Nos. 5,017,381 and 6,228,398. See id. col.7 …simultaneouslyā€¯); U.S. Patent 9 No. 6,228,398 col.4 ll.56-59 (…to in the patent, 09:26:38 5 be relative because they're what the patent is teaching…teaching that the patent, that there's any 09:29:12 15 patent says is there…#x27;707 patent? 11:01:14 18 is used in the claims of the '707 patent? 10:57:56 | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |